Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FCR in Chronic Lymphocytic Leukemia
NCT00812669Phase 2Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Aug 2008
- Primary completion
- Nov 2019
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, cyclophosphamide, rituximab in chronic lymphocytic leukemia (CLL), sponsored by Cancer Trials Ireland. Started Aug 2008; status: completed.
02
Drugs
fludarabinecyclophosphamiderituximab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00812669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812669.